Clinical Trial Update: The Use of Intranasal Fentanyl for the Treatment of Incident Dyspnea in Congestive Heart Failure: A Prospective Trial [Phase 2]

View source ↗

Summary

Phase 2 trial investigating intranasal fentanyl for incident dyspnea in congestive heart failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyspnea
• Heart Failure

Drugs mentioned

• Intranasal fentanyl (fentanyl)

Snippet

Sponsor: St. Boniface Hospital | Conditions: Dyspnea, Congestive Heart Failure | Phase 2 | Status: COMPLETED